• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管存在卫生系统限制,但实施成功的原因:对复方新诺明预防治疗“有效因素”的定性见解。

Reasons for implementation success despite health system constraints: qualitative insights on 'what worked' for cotrimoxazole preventive therapy.

机构信息

Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.

Faculdade de Medicina, Universidade Eduardo Mondlane, Maputo, Mozambique.

出版信息

BMC Health Serv Res. 2024 Mar 27;24(1):379. doi: 10.1186/s12913-024-10631-x.

DOI:10.1186/s12913-024-10631-x
PMID:38539249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10967051/
Abstract

BACKGROUND

Although Cotrimoxazole preventive therapy (CPT) has shown to be highly efficacious in reducing morbidity and mortality among people living with Human immunodeficiency virus (HIV) under 'ideal world' study conditions, operational challenges are limiting its effectiveness when implementing in countries most affected by the HIV epidemic. The fact that Mozambican authorities reported high coverage of CPT among patients with HIV, has led to this qualitative case study aimed at exploring possible factors responsible for the successful implementation of CPT in the Province of Maputo.

METHODS

Between February and April 2019, we individually interviewed nine governmental stakeholders, including the person responsible for the HIV Program, the person responsible for the TB Program and the person responsible for Pharmaceutical management at three administrative levels (central, provincial and district level). Interviews were recorded, transcribed, and analysed thematically using MAXQDA Analytics Pro. Findings were translated from Portuguese into English.

RESULTS

Five themes iteratively emerged: (a) Role of governance & leadership, (b) Pharmaceutical strategies, (c) Service delivery modifications, (d) Health care provider factors, and (e) Patients' perspectives. Interviews revealed that continuous supply of cotrimoxazole (CTZ) had been facilitated through multiple-source procurement and a push-pull strategy. One part of CTZ arrived in kits that were imported from overseas and distributed to public health facilities based on their number of outpatient consultations (push strategy). Another part of CTZ was locally produced and distributed as per health facility demand (pull strategy). Strong district level accountability also contributed to the public availability of CTZ. Interviewees praised models of differentiated care, the integrated HIV service delivery and drug delivery strategies for reducing long queues at the health facility, better accommodating patients' needs and reducing their financial and organisational burden.

CONCLUSIONS

This study presents aspects that governmental experts believed to be key for the implementation of CPT in the Province of Maputo, Mozambique. Enhancing the implementation outcomes - drug availability and feasibility of the health facility-based service delivery - seemed crucial for the implementation progress. Reasons for the remarkable patient acceptability of CPT in our study setting should be further investigated.

摘要

背景

尽管复方新诺明预防疗法(CPT)在“理想世界”的研究条件下已被证明对降低艾滋病毒(HIV)感染者的发病率和死亡率非常有效,但在受 HIV 流行影响最严重的国家实施时,其实施面临的操作挑战限制了其效果。莫桑比克当局报告称,HIV 感染者的 CPT 覆盖率很高,这导致了这项定性案例研究,旨在探索莫桑比克马普托省成功实施 CPT 的可能因素。

方法

2019 年 2 月至 4 月,我们对 9 名政府利益攸关方进行了个人访谈,包括 HIV 项目负责人、结核病项目负责人以及三个行政级别(中央、省和地区)的药物管理负责人。访谈进行了录音、转录,并使用 MAXQDA Analytics Pro 进行了主题分析。研究结果从葡萄牙语翻译成了英语。

结果

五个主题反复出现:(a)治理和领导作用,(b)药物策略,(c)服务提供方式的改变,(d)医疗保健提供者的因素,以及(e)患者的观点。访谈表明,通过多渠道采购和推-拉策略,持续供应复方新诺明(CTZ)已成为可能。一部分 CTZ 装在从海外进口的试剂盒中,根据门诊就诊人数分配给公共卫生机构(推策略)。另一部分 CTZ 是根据卫生机构的需求生产和分配的(拉策略)。强有力的区级问责制也有助于 CTZ 的普及。受访者称赞了差异化护理模式、整合的 HIV 服务提供和药物提供策略,这些策略减少了卫生机构的长队,更好地满足了患者的需求,减轻了他们的经济和组织负担。

结论

本研究介绍了莫桑比克马普托省政府专家认为实施 CPT 的关键方面。增强实施结果——药物的可获得性和基于卫生机构的服务提供的可行性——似乎对实施进展至关重要。我们研究环境中 CPT 患者接受度显著的原因应进一步调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/10967051/78e6354189e9/12913_2024_10631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/10967051/78e6354189e9/12913_2024_10631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/10967051/78e6354189e9/12913_2024_10631_Fig1_HTML.jpg

相似文献

1
Reasons for implementation success despite health system constraints: qualitative insights on 'what worked' for cotrimoxazole preventive therapy.尽管存在卫生系统限制,但实施成功的原因:对复方新诺明预防治疗“有效因素”的定性见解。
BMC Health Serv Res. 2024 Mar 27;24(1):379. doi: 10.1186/s12913-024-10631-x.
2
Tuberculosis结核病
3
Managers' and providers' perspectives on barriers and facilitators for the implementation of differentiated service delivery models for HIV treatment in Mozambique: a qualitative study.管理者和提供者对莫桑比克实施艾滋病毒治疗差异化服务提供模式的障碍和促进因素的看法:一项定性研究。
J Int AIDS Soc. 2023 Mar;26(3):e26076. doi: 10.1002/jia2.26076.
4
Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV.混合方法系统评价和荟萃分析,探讨了在艾滋病毒感染者中实施复方新诺明和异烟肼预防性治疗的障碍和促进因素。
PLoS One. 2022 Mar 1;17(3):e0251612. doi: 10.1371/journal.pone.0251612. eCollection 2022.
5
Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.马拉维的运营研究:在结核和艾滋病毒患者中使用复方新诺明预防性治疗带来的改变。
BMC Public Health. 2011 Jul 27;11:593. doi: 10.1186/1471-2458-11-593.
6
Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.了解乌干达国家扩大差异化抗逆转录病毒治疗服务中的实施障碍。
BMC Health Serv Res. 2020 Mar 17;20(1):222. doi: 10.1186/s12913-020-5069-y.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?博茨瓦纳马哈拉皮耶结核病与艾滋病毒合并感染患者的死亡率回顾:复方新诺明预防性治疗和/或抗逆转录病毒疗法能否预防死亡?
Afr J Prim Health Care Fam Med. 2018 Nov 15;10(1):e1-e5. doi: 10.4102/phcfm.v10i1.1765.
9
Availability and acceptability of HIV counselling and testing services. A qualitative study comparing clients' experiences of accessing HIV testing at public sector primary health care facilities or non-governmental mobile services in Cape Town, South Africa.艾滋病毒咨询与检测服务的可及性与可接受性。一项定性研究,比较南非开普敦公共部门初级卫生保健机构或非政府流动服务机构中客户进行艾滋病毒检测的经历。
BMC Public Health. 2015 Sep 2;15:845. doi: 10.1186/s12889-015-2173-8.
10
The views of public service managers on the implementation of National Health Insurance in primary care: a case of Johannesburg Health District, Gauteng Province, Republic of South Africa.南非共和国豪登省约翰内斯堡卫生区:基层医疗实施国家健康保险计划中公共服务管理者的观点。
BMC Health Serv Res. 2021 Sep 15;21(1):969. doi: 10.1186/s12913-021-06990-4.

本文引用的文献

1
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.衡量卫生人力资源的可及性及其与 1990 年至 2019 年 204 个国家和地区全民健康覆盖的关系:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Jun 4;399(10341):2129-2154. doi: 10.1016/S0140-6736(22)00532-3. Epub 2022 May 23.
2
Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV.混合方法系统评价和荟萃分析,探讨了在艾滋病毒感染者中实施复方新诺明和异烟肼预防性治疗的障碍和促进因素。
PLoS One. 2022 Mar 1;17(3):e0251612. doi: 10.1371/journal.pone.0251612. eCollection 2022.
3
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.在乌干达,停止接受抗逆转录病毒治疗稳定的 HIV 感染成人的复方新诺明预防治疗(COSTOP):一项随机安慰剂对照试验。
PLoS One. 2018 Dec 31;13(12):e0206907. doi: 10.1371/journal.pone.0206907. eCollection 2018.
4
Provision of medical supply kits to improve quality of antenatal care in Mozambique: a stepped-wedge cluster randomised trial.向莫桑比克提供医疗供应包以改善产前护理质量:一项 stepped-wedge 集群随机试验。
Lancet Glob Health. 2018 Jan;6(1):e57-e65. doi: 10.1016/S2214-109X(17)30421-7.
5
Cotrimoxazole, a wonder drug in the era of multiresistance: Case report and review of literature.复方新诺明,多重耐药时代的神奇药物:病例报告及文献综述
J Lab Physicians. 2017 Jul-Sep;9(3):210-213. doi: 10.4103/0974-2727.208261.
6
Improved HIV and TB Knowledge and Competence Among Mid-level Providers in a Cluster-Randomized Trial of One-on-One Mentorship for Task Shifting.在一项关于任务转移的一对一指导的整群随机试验中,中级医疗服务提供者的艾滋病毒和结核病知识及能力得到提高。
J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):e120-e127. doi: 10.1097/QAI.0000000000001378.
7
Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania.在坦桑尼亚公共卫生机构中,对感染艾滋病毒的孕妇实施复方新诺明预防疟疾治疗政策。
Drug Healthc Patient Saf. 2016 Dec 13;8:91-100. doi: 10.2147/DHPS.S119073. eCollection 2016.
8
The History of the HIV/AIDS Epidemic in Africa.非洲艾滋病毒/艾滋病流行史。
Curr HIV/AIDS Rep. 2016 Aug;13(4):187-93. doi: 10.1007/s11904-016-0318-8.
9
Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities.在公共卫生机构中,为感染艾滋病毒母亲所生儿童有效实施复方新诺明预防措施面临的挑战。
Drug Healthc Patient Saf. 2015 Oct 29;7:147-56. doi: 10.2147/DHPS.S89115. eCollection 2015.
10
Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.复方新诺明预防成人(包括孕妇)艾滋病毒感染:系统评价和荟萃分析。
Lancet HIV. 2015 Apr;2(4):e137-50. doi: 10.1016/S2352-3018(15)00005-3. Epub 2015 Mar 3.